Blend Labs insider plans sale of 21,009 shares

A Rule 144 notice discloses that a company insider plans to sell 21,009 Blend Labs shares, with prior recent sales also reported.

Rhea-AI Filing Summary

Blend Labs, Inc. (BLND) received a Rule 144 notice from Nima Ghamsari covering a proposed sale of 21,009 shares of common stock through Charles Schwab & Co. The filing lists an aggregate market value of about $25,024 for these shares and an approximate sale date of September 21, 2026.

The notice also reports that Blend Labs had 233,256,934 shares of common stock outstanding, and that during the prior three months Ghamsari sold 17,731 shares for an aggregate value of about $25,267.

Key Figures

Shares proposed to be sold: 21,009 shares of common stock Aggregate market value of proposed sale: $25,024 Shares outstanding: 233,256,934 shares +4 more

7 metrics

Shares proposed to be sold 21,009 shares of common stock Proposed sale by Nima Ghamsari under Rule 144

Aggregate market value of proposed sale $25,024 Value of the 21,009 shares proposed to be sold

Shares outstanding 233,256,934 shares Blend Labs common stock outstanding when the notice was prepared

Approximate sale date September 21, 2026 Approximate date for the proposed Rule 144 sale

Recent shares sold 17,731 shares Shares sold by Nima Ghamsari on September 14, 2026

Aggregate value of recent sale $25,267 Value of the 17,731 shares sold during the prior three months

Acquisition date of shares November 20, 2025 Date of Restricted Stock Lapse for the shares being sold

Key Terms

Rule 144, Restricted Stock Lapse, Equity Compensation

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Lapse financial

"Common | 11/20/2025 | Restricted Stock Lapse | BLEND LABS, INC."

Equity Compensation financial

"21009 | 11/20/2025 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider sale is disclosed for BLND in this Rule 144 filing?

The notice discloses a proposed sale of 21,009 shares of Blend Labs, Inc. common stock by Nima Ghamsari under Rule 144, with an approximate aggregate market value of $25,024 and an approximate sale date of September 21, 2026.

Who is the selling security holder in this Blend Labs (BLND) Rule 144 notice?

The selling security holder is Nima Ghamsari. The notice states that the proposed sale of Blend Labs, Inc. common stock is for this person’s account, with information provided as required under Rule 144.

How many Blend Labs (BLND) shares are outstanding according to the notice?

The Rule 144 notice reports that Blend Labs, Inc. had 233,256,934 shares of common stock outstanding. This figure is provided as context for the proposed insider sale amount.

What recent sales by Nima Ghamsari in BLND shares are reported?

The filing reports that on September 14, 2026, Nima Ghamsari sold 17,731 shares of Blend Labs, Inc. common stock, with an aggregate market value of about $25,267 during the prior three months.

What is the origin of the Blend Labs (BLND) shares proposed for sale?

The securities to be sold are Blend Labs, Inc. common stock acquired on November 20, 2025 in connection with a Restricted Stock Lapse classified as Equity Compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/21/2026 - 04:18 PM Accepted by SEC EDGAR 09/21/2026 - 04:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001870974
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Blend Labs, Inc.
SEC File Number	001-40599
Address of Issuer	7250 REDWOOD BLVD., SUITE 300 NOVATO CALIFORNIA 94945
Phone	(650) 550-4810
Name of Person for Whose Account the Securities are To Be Sold	Ghamsari Nima
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	21009	25024.00	233256934	09/21/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/20/2025	Restricted Stock Lapse	BLEND LABS, INC.			21009	11/20/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NIMA GHAMSARI 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 76262	Blend Labs, Inc.	09/14/2026	17731	25267.00

144: Remarks and Signature

Remarks
Date of Notice	09/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	NIMA GHAMSARI
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)